European Drug Report 2022: Trends and Developments
Introduction
The Trends and Developments report presents the EMCDDA’s latest analysis of the drug situation in Europe. Focusing on illicit drug use, related harms and drug supply, the report contains a comprehensive set of national data across these themes and key harm-reduction interventions.
Download as PDF
- Bulgarian (bg)
- Croatian (hr)
- Czech (cs)
- Danish (da)
- Dutch (nl)
- English (en)
- Estonian (et)
- Finnish (fi)
- French (fr)
- German (de)
- Greek (el)
- Hungarian (hu)
- Irish (ga)
- Italian (it)
- Latvian (lv)
- Lithuanian (lt)
- Norwegian (no)
- Polish (pl)
- Portuguese (pt)
- Romanian (ro)
- Slovakian (sk)
- Slovene (sl)
- Spanish (es)
- Swedish (sv)
- Turkish (tr)
Table of contents
- Preface
- Introductory note
- Acknowledgements
- The drug situation in Europe up to 2022 — An overview and assessment of emerging threats and new developments
- Drug supply, production and precursors
- Cannabis
- Cocaine
- Amphetamine and metamphetamine
- MDMA
- Heroin and other opioids
- New psychoactive substances
- Other drugs
- Annex — National data tables
Pages:
60
ISBN:
978-92-9497-742-7
ISSN:
ISSN 2314-9086
Pub. DOI:
10.2810/75644
Catalog Number:
TDAT22001ENN
Main subject
Keywords
- amphetamine
- cocaine
- COVID-19
- darknet
- DRD (key indicator)
- drug law offences
- drug markets
- drug situation
- drug-related deaths
- drug-related infectious diseases
- GHB
- harm reduction
- health and social responses
- health harms of drug use
- hepatitis B virus (HBV)
- hepatitis C virus (HCV)
- heroin
- HIV
- hospital emergencies
- ketamine
- law
- legislation and laws
- LSD
- MDMA/ecstasy
- methamphetamine
- NPS
- opioids
- precursors
- price
- production of drugs
- supply of drugs
- synthetic cannabinoids
- synthetic cathinones
- TDI (key indicator)
- treatment monitoring
- wastewater analysis